ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2017

Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program.

M González-Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.